The 20 Best Relapsed Refractory Multiple Myeloma (RRMM) Doctors in California, US

Gary Schiller is an Oncologist in Los Angeles, California. Dr. Schiller is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Ajai Chari is an Oncologist in San Francisco, California. Dr. Chari is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Deepu Madduri is a Hematologist and an Oncologist in Palo Alto, California. Dr. Madduri is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Amrita Krishnan is an Oncologist in Irvine, California. Dr. Krishnan is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Robert Vescio is a Hematologist and an Oncologist in Tarzana, California. Dr. Vescio is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Bone Tumor, Cardiac Amyloidosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Vescio is currently accepting new patients.

Jeffrey Wong is a Radiation Oncologist in Duarte, California. Dr. Wong is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Relapsed Refractory Multiple Myeloma (RRMM), and Primitive Neuroectodermal Tumor (PNET).

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Nancy Sze Wan Wong is a nurse practitioner who cares for patients with blood disorders. Her expertise includes chronic blood disorders that surface suddenly and require immediate treatment. Wong is passionate about caring for patients with cancers of the blood. She aims to help her patients learn more about their condition in addition to helping them manage their symptoms during recovery. Wong earned her master's degree in nursing at Samuel Merritt University. She is a member of the Oncology Nursing Society. A native of San Francisco, Wong enjoys spending time with her family, reading and hiking. Ms. Wong is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.

Surbhi Sidana is a Hematologist in Palo Alto, California. Dr. Sidana is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Smoldering Multiple Myeloma, Bone Marrow Transplant, and Thyroidectomy.

Dr. Shagun Arora is a hematologist-oncologist who specializes in caring for patients with malignant and classical (cancerous and noncancerous) blood disorders. She treats patients with diverse hematologic conditions in both categories. Her focus is monoclonal gammopathies, or conditions in which the blood contains abnormal proteins, including MGUS (monoclonal gammopathy of undetermined significance) and multiple myeloma, along with anemias. Arora's goal is to provide compassionate, supportive care that takes the whole person into consideration, while helping patients fight cancer. She considers it a privilege to be part of the lives of cancer patients and their families. In addition to patient care, she is passionate about medical education, working closely with training physicians who are pursuing fellowships in hematology and oncology. Arora is the medical director of the Infusion Center at UCSF's Parnassus campus. Arora completed her residency at Michigan State University, followed by a fellowship at MedStar Washington Hospital Center and MedStar Georgetown University Hospital, where she served as chief fellow. She is a member of several professional associations, including the American Society of Hematology, American Society of Clinical Oncology, Society of Hematologic Oncology and International Myeloma Society. In her free time, Arora enjoys international travel, yoga retreats and hiking to view the gorgeous vistas of San Francisco. Dr. Arora is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Jarrod Holmes is a Hematologist Oncology specialist and a Hematologist in Santa Rosa, California. Dr. Holmes is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Waldenstrom Macroglobulinemia, Chronic Lymphocytic Leukemia (CLL), Breast Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Holmes is currently accepting new patients.

Dr. Thomas M. Link is chief of the musculoskeletal imaging section in the UCSF Department of Radiology and Biomedical Imaging. As clinical director of the department's Musculoskeletal Quantitative Imaging Research (MQIR) group, he has a strong interest in translational research (using study findings to establish new treatments or diagnostic methods). The main focuses of MQIR are: imaging of osteoporosis, particularly developing new techniques for assessing bone quality and density; applying new imaging techniques to the assessment of osteoarthritis and cartilage, and to preventing cartilage degeneration; new imaging sequences for musculoskeletal imaging at high field; and MR-guided high-intensity focused ultrasound for treatment of bony abnormalities. Link earned his medical degree at Johannes Gutenberg University Mainz in Germany. He completed his medical residency in Münster, Germany. He completed a research fellowship in radiology at UCSF. Link was a vice chair in the radiology department at the Technical University of Munich before joining UCSF in 2003. Dr. Link is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Sandhaus Ben-Ami Syndrome, Synovitis, MAGIC Syndrome, Endoscopy, and Hip Replacement.

Dr. Bradley Ekstrand is a genitourinary oncologist who has particular interest and expertise in treating patients with lymphoma and genitourinary cancers. His background in the molecular biology of cancer gives him a unique perspective, combining a scientist's view of disease with a doctor's expertise, to bring the best care to patients with cancer. Ekstrand earned his medical degree from Yale School of Medicine, where he also completed a doctorate in cancer biology. During his doctoral studies, he worked in the lab of acclaimed cancer genetics researcher Dr. Eric Fearon, where he focused on tumor suppressor genes. He completed a residency in internal medicine at Mount Sinai Medical Center and a fellowship in medical oncology at Stanford University School of Medicine. During his fellowship, he worked extensively in lymphoma with Drs. Sandra Horning and Gilbert Chu. Ekstrand is a member of the American Society of Clinical Oncology and Association of Northern California Oncologists, where he serves as vice president. Through his work with these organizations, he advocates for high-quality cancer care for all patients. A native of Boulder, Colorado, Ekstrand enjoys outdoor recreation, particularly alpine skiing, swimming and long-distance running. Outside of work, he devotes most of his time to family activities with his wife and three children. An avid sports fan, he follows Stanford athletics, European soccer leagues and the Denver Broncos. Dr. Ekstrand is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Follicular Lymphoma, Familial Prostate Cancer, Small Lymphocytic Lymphoma (SLL), and Large-Cell Immunoblastic Lymphoma.

Oleg Krijanovski is a Hematologist in Berkeley, California. Dr. Krijanovski is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is currently accepting new patients.

Yi-jen Chen is a Radiation Oncologist in Arcadia, California. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Anal Cancer, Gastroesophageal Junction Cancer, Endometrial Cancer, Ureteral Reconstruction, and Endoscopy.

Parag Sanghvi is a Radiation Oncologist in La Jolla, California. Dr. Sanghvi is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Laryngeal Cancer, Hodgkin Lymphoma, Adenoid Cystic Carcinoma, and Posterior Fossa Tumor.

Sagus Sampath is a Radiation Oncologist in Duarte, California. Dr. Sampath is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adult Soft Tissue Sarcoma, Bone Tumor, and Prostatectomy.